Comparative genomic hybridization in childhood acute lymphoblastic leukemia

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Childhood acute lymphoblastic leukemia (ALL) is a significant pediatric malignancy.
• Understanding genetic alterations in ALL is crucial for diagnosis and prognosis.
• Comparative genomic hybridization (CGH) is a valuable tool for detecting DNA copy number changes.

Purpose of the Study:

• To investigate DNA copy number alterations in childhood acute lymphoblastic leukemia (ALL) at diagnosis using CGH.
• To correlate CGH findings with traditional cytogenetic analyses.
• To identify specific chromosomal regions frequently gained or lost in ALL.

Main Methods:

• Comparative genomic hybridization (CGH) was performed on bone marrow samples from 72 children with ALL.
• Samples were collected at diagnosis between 1982 and 1997.
• CGH results were compared with chromosome banding analysis.

Main Results:

• DNA copy number changes were detected in 62.5% of patients, with an average of 4.6 aberrations per patient.
• DNA copy number gains were significantly more frequent than losses (6:1 ratio).
• Frequent gains involved chromosomes 21, 18, X, 10, and 17; common losses included 9p and 12p regions.

Conclusions:

• CGH is effective in detecting DNA copy number changes in childhood ALL, often complementing standard karyotyping.
• Specific chromosomal gains, particularly involving chromosomes 21, 18, and X, are common in pediatric ALL.
• No significant association was found between CGH findings and diagnostic white blood cell counts.